Diagnostics & Research earnings calendar: upcoming and recent reports
33 Diagnostics & Research companies report earnings over the next 45 days, led by Natera (NTRA), AgileThought (A) and Waters (WAT). 12 reported over the last 45 days; 100% of those with an EPS estimate came in above it and the average move around the report was 5.1%.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS Signals lists the biggest reports of the week, with ATLAS’s read on each, plus three stocks on our radar. One email, one-click unsubscribe.
ATLAS Signals
ATLAS Signals, every week
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy
Diagnostics & Research: upcoming earnings (next 45 days)
| Company | Date | Time | EPS est. | ATLAS chance up (1 mo) | Likely range (50%) | Fair value vs price |
|---|---|---|---|---|---|---|
| IDEXX Laboratories IDXX · ATLAS page | Mon, Nov 2 | Before open | $3.71 | 51% | $523.23 – $582.73 | $329.05 ($240.73–$449.79) · 68% above |
| Waters WAT · ATLAS page | Tue, Nov 3 | Before open | $3.99 | 51% | $440.30 – $488.31 | – |
| Revvity RVTY · ATLAS page | Tue, Nov 3 | Before open | $1.29 | 50% | $147.57 – $167.16 | $76.74 ($45.67–$91.41) · 105% above |
| Sotera Health SHC · ATLAS page | Tue, Nov 3 | Before open | $0.24 | 51% | $17.30 – $19.13 | $24.84 ($17.95–$34.03) · 27% below |
| Personalis PSNL · ATLAS page | Tue, Nov 3 | After close | -$0.25 | 48% | $14.42 – $17.18 | – |
| Charles River Laboratories International CRL · ATLAS page | Wed, Nov 4 | Before open | $2.98 | 49% | $329.87 – $388.76 | – |
| Qiagen N.V. QGEN · ATLAS page | Wed, Nov 4 | After close | $0.63 | 51% | $47.93 – $52.88 | $51.30 ($40.82–$64.46) · 2% below |
| GRAIL GRAL · ATLAS page | Wed, Nov 4 | After close | -$2.78 | 44% | $116.51 – $164.38 | – |
| BillionToOne BLLN · ATLAS page | Wed, Nov 4 | After close | $0.16 | 47% | $100.02 – $125.33 | – |
| Adaptive Biotechnologies ADPT · ATLAS page | Wed, Nov 4 | After close | -$0.10 | 47% | $23.65 – $29.37 | $15.67 ($14.10–$17.24) · 70% above |
| Veracyte VCYT · ATLAS page | Wed, Nov 4 | After close | $0.28 | 48% | $45.06 – $54.69 | $33.81 ($22.82–$34.13) · 48% above |
| OPKO Health OPK · ATLAS page | Wed, Nov 4 | After close | -$0.07 | 47% | $1.47 – $1.83 | $1.05 ($0.94–$1.15) · 59% above |
| Myriad Genetics MYGN · ATLAS page | Wed, Nov 4 | After close | -$0.25 | 44% | $5.15 – $7.28 | – |
| Natera NTRA · ATLAS page | Thu, Nov 5 | After close | -$0.17 | 49% | $381.89 – $446.91 | $139.02 ($125.12–$152.93) · 198% above |
| Mettler-Toledo International MTD · ATLAS page | Thu, Nov 5 | After close | $12.11 | 52% | $1,603.55 – $1,759.14 | $813.86 ($503.95–$1,314.33) · 106% above |
| Guardant Health GH · ATLAS page | Thu, Nov 5 | After close | -$0.68 | 48% | $162.91 – $194.27 | – |
| Castle Biosciences CSTL · ATLAS page | Thu, Nov 5 | After close | -$0.38 | 48% | $33.45 – $40.67 | $94.95 ($85.45–$104.44) · 61% below |
| Fulgent Genetics FLGT · ATLAS page | Thu, Nov 5 | After close | $1.00 | 49% | $18.97 – $22.27 | – |
| Biodesix BDSX · ATLAS page | Thu, Nov 5 | After close | -$0.74 | 46% | $19.90 – $26.12 | – |
| RadNet RDNT · ATLAS page | Mon, Nov 9 | Before open | $0.21 | 50% | $69.14 – $78.19 | $40.61 ($30.65–$53.81) · 81% above |
| GeneDx WGS · ATLAS page | Mon, Nov 9 | After close | $0.07 | 45% | $56.64 – $78.87 | – |
| Insight Molecular Diagnostics IMDX · ATLAS page | Mon, Nov 9 | After close | -$0.22 | 45% | $2.49 – $3.35 | – |
| Freenome FRNM · ATLAS page | Tue, Nov 10 | After close | – | 47% | $10.91 – $13.87 | – |
| Exagen XGN · ATLAS page | Tue, Nov 10 | Before open | -$0.19 | 47% | $7.54 – $9.53 | – |
| Precipio PRPO · ATLAS page | Tue, Nov 10 | After close | – | 48% | $16.27 – $19.82 | $6.80 ($5.68–$8.32) · 166% above |
| MDxHealth SA MDXH · ATLAS page | Wed, Nov 11 | – | -$0.07 | 39% | $0.10 – $0.19 | – |
| Quantum Cyber N.V. QUCY · ATLAS page | Fri, Nov 13 | – | -$0.08 | 43% | $0.66 – $0.97 | – |
| ENDRA Life Sciences NDRA · ATLAS page | Fri, Nov 13 | – | -$0.84 | 46% | $4.04 – $5.35 | – |
| XWELL XWEL · ATLAS page | Fri, Nov 13 | – | – | 46% | $0.59 – $0.78 | – |
| BioAffinity Technologies BIAF · ATLAS page | Fri, Nov 13 | – | – | 40% | $1.98 – $3.47 | – |
| iSpecimen ISPC · ATLAS page | Mon, Nov 16 | – | – | 45% | $0.70 – $0.94 | – |
| Advanced Biomed ADVB · ATLAS page | Wed, Nov 18 | – | – | 42% | $1.70 – $2.71 | – |
| AgileThought A · ATLAS page | Mon, Nov 23 | After close | $1.72 | 51% | $166.52 – $184.44 | $91.09 ($55.27–$150.12) · 92% above |
ATLAS columns: chance of a higher price in 1 month, the likely 1-month price range and the fair value with its range, from each company’s ATLAS page. They describe an ordinary period, not the earnings reaction.
Diagnostics & Research: recent earnings results (last 45 days)
| Company | Date | Time | EPS est. | EPS reported | Surprise | Move* | ATLAS chance up (1 mo) | Likely range (50%) | Fair value vs price |
|---|---|---|---|---|---|---|---|---|---|
| Illumina ILMN · ATLAS page | Thu, Oct 29 | – | $1.36 | $1.44 | – | – | 45% | $199.19 – $266.52 | $127.19 ($83.08–$194.70) · 86% above |
| CareDx CDNA · ATLAS page | Thu, Oct 29 | – | $0.07 | $0.52 | +642.9% | – | 45% | $73.26 – $99.01 | $68.56 ($50.99–$91.25) · 28% above |
| Labcorp LH · ATLAS page | Wed, Oct 28 | – | $4.65 | $4.78 | +2.8% | – | 50% | $340.83 – $383.86 | $321.23 ($228.58–$451.44) · 13% above |
| NeoGenomics NEO · ATLAS page | Wed, Oct 28 | – | -$0.01 | $0.01 | +200.0% | – | 48% | $15.62 – $19.04 | $49.78 ($44.80–$54.76) · 65% below |
| IQVIA IQV · ATLAS page | Tue, Oct 27 | – | $2.94 | $2.95 | +0.3% | +2.0% | 51% | $254.19 – $282.27 | $246.12 ($195.53–$309.79) · 9% above |
| ICON ICLR · ATLAS page | Tue, Oct 27 | – | $2.40 | $2.46 | +2.5% | +16.5% | 47% | $187.42 – $233.20 | $149.03 ($122.01–$223.03) · 42% above |
| GeneDx WGS · ATLAS page | Tue, Oct 27 | – | $0.07 | – | -100.0% | +5.6% | 45% | $56.64 – $78.87 | – |
| Quest Diagnostics DGX · ATLAS page | Thu, Oct 22 | – | $2.85 | $3.00 | +5.3% | +1.2% | 53% | $243.31 – $262.61 | $284.18 ($222.30–$363.29) · 11% below |
| Thermo Fisher Scientific TMO · ATLAS page | Wed, Oct 21 | – | $6.40 | $6.68 | +4.4% | -1.6% | 52% | $668.05 – $731.49 | $399.44 ($299.99–$531.86) · 74% above |
| Danaher DHR · ATLAS page | Wed, Oct 21 | – | $1.92 | $2.11 | +9.9% | +2.5% | 51% | $221.51 – $244.62 | $141.13 ($81.51–$169.69) · 65% above |
| Medpace MEDP · ATLAS page | Wed, Oct 21 | – | $4.45 | $4.84 | +8.8% | +5.1% | 50% | $611.01 – $695.65 | $679.07 ($546.75–$843.41) · 4% below |
| Danaher DHR · ATLAS page | Wed, Sep 30 | – | $4.08 | $4.40 | +7.8% | -6.4% | 51% | $221.51 – $244.62 | $141.13 ($81.51–$169.69) · 65% above |
ATLAS columns: chance of a higher price in 1 month, the likely 1-month price range and the fair value with its range, from each company’s ATLAS page. They describe an ordinary period, not the earnings reaction.
*Move: change in the closing price from the last close before the report day to the close the day after it.
Largest Diagnostics & Research companies and their next report
- Thermo Fisher Scientific (TMO)
- Danaher (DHR)
- Natera (NTRA) · Nov 5
- AgileThought (A) · Nov 23
- Waters (WAT) · Nov 3
- IQVIA (IQV)
- Illumina (ILMN)
- IDEXX Laboratories (IDXX) · Nov 2
- Mettler-Toledo International (MTD) · Nov 5
- Labcorp (LH)
- Quest Diagnostics (DGX)
- Guardant Health (GH) · Nov 5
- Revvity (RVTY) · Nov 3
- Medpace (MEDP)
- Charles River Laboratories International (CRL) · Nov 4
- ICON (ICLR)
- Qiagen N.V. (QGEN) · Nov 4
- GRAIL (GRAL) · Nov 4
- RadNet (RDNT) · Nov 9
- BillionToOne (BLLN) · Nov 4
- Sotera Health (SHC) · Nov 3
- Adaptive Biotechnologies (ADPT) · Nov 4
- CareDx (CDNA)
- Veracyte (VCYT) · Nov 4
- NeoGenomics (NEO)
- GeneDx (WGS) · Nov 9
- Freenome (FRNM) · Nov 10
- Personalis (PSNL) · Nov 3
- OPKO Health (OPK) · Nov 4
- Castle Biosciences (CSTL) · Nov 5
- Fulgent Genetics (FLGT) · Nov 5
- Myriad Genetics (MYGN) · Nov 4
- Biodesix (BDSX) · Nov 5
- Exagen (XGN) · Nov 10
- Insight Molecular Diagnostics (IMDX) · Nov 9
- Quantum Cyber N.V. (QUCY) · Nov 13
Earnings calendar: frequently asked questions
Which Diagnostics & Research companies report earnings soon?
Natera (NTRA), AgileThought (A), Waters (WAT), IDEXX Laboratories (IDXX), Mettler-Toledo International (MTD) and Guardant Health (GH) are among the largest Diagnostics & Research reports scheduled in the next 45 days. 33 are listed with a confirmed date.
How many Diagnostics & Research companies beat EPS estimates?
Of the 11 Diagnostics & Research companies that reported over the last 45 days with an EPS estimate on record, 11 (100%) reported EPS above the estimate. That is a snapshot of one window, not a forecast.
Where do these Diagnostics & Research dates come from?
Dates are confirmed report dates from company and exchange data, refreshed daily. Estimated dates are never shown here; only individual company pages show an ATLAS estimate, clearly labelled.
What is the difference between before the open and after the close?
Reports released before the open (BMO) move the stock in that same session. Reports released after the close (AMC) are first reflected the next trading day. ATLAS shows the time when the exchange data provides it.
Other industries
- Full US earnings calendar
- Biotechnology earnings
- Banks - Regional earnings
- Software - Application earnings
- Software - Infrastructure earnings
- Medical Devices earnings
- Asset Management earnings
- Aerospace & Defense earnings
- Capital Markets earnings
- Drug Manufacturers - Specialty & Generic earnings
- Specialty Industrial Machinery earnings
- Information Technology Services earnings
- Oil & Gas E&P earnings
Open any company page to set an email alert for its next report. Looking for a single stock? Try Apple (AAPL).
Educational information, not investment advice. Disclaimer